Archives for July 2019

Congrats Douglas Martin for receiving a 2019 RSNA Roentgen Resident/Fellow Research Award!!!

Congratulations to our lab members who have recently received fellowships!

James Bishop has been awarded a Ruth L. Kirschstein National Research Service Award (NRSA) F32 Postdoctoral Fellowship! This competitive grant is awarded by the NIH on a national basis for highly promising postdoctoral candidates to support their potential to become productive, independent investigators in scientific health-related research fields. He will be working on drug uncaging technologies to alleviate chronic pain.

Tommaso Di Ianni was awarded a School of Medicine Dean’s Postdoctoral Fellowship, a highly competitive fellowship to support young investigators in the first two years of their postdoctoral research training. Tommaso is working on designing ultrasound transducers that will enable behavioral studies in awake freely-moving animals, along with functional ultrasound to imaging brain activity in real time.

Daivik Vyas has been rewarded a MedScholars Fellowship to conduct research on using ultrasound to modulate the glymphatic system for drug delivery. The MedScholars program provides funding for Stanford medical students to conduct research in basic, clinical, and translational settings.

Jeff Wang has been rewarded a Stanford Interdisciplinary Graduate Fellowship (SIGF) to characterize whole-brain oscillatory, metabolic, and behavioral changes associated with localized ketamine uncaging. The SIGF is a competitive, university-wide award given to doctoral students engaged in interdisciplinary research in humanities, social sciences, basic sciences, and engineering.

Congrats again to all!

Qian and Jason’s paper “Polymeric perfluorocarbon nanoemulsions are ultrasound-activated wireless drug infusion catheters” is now published in Biomaterials. Congrats to the authors!

Here, we show that nanoparticle-mediated ultrasonic drug uncaging is generalizable to a wide range of hydrophobic drugs and also demonstrate the needed stability and drug loading for clinical translation. Given this wide range of drugs, we have the potential to potentially treat diseases as wide-ranging as cancer, neuropsychiatric disorders, and stroke. The paper can be found here: